Reducing severe bleeding in trauma patients using expandable foam

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the safety and effectiveness of ResQFoam for treating exsanguinating intra-abdominal hemorrhage in trauma patients requiring emergency surgery. Patients aged 15 and older with significant abdominal bleeding will receive the foam within 30 minutes of arriving at the emergency department. The foam is intended to stabilize the patient before definitive surgical intervention, which is expected to occur within three hours of foam application. The study will assess the benefit-risk profile of this innovative treatment approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Estimated age of 15 years or older (or subject weight estimated at greater than 50 kg if age is unknown)
2. Emergent, exsanguinating hemorrhage, from abdominal source as defined by:

   * Class III or IV hemorrhagic shock or
   * Assessment of Blood Consumption (ABC) score ≥ 2
3. Confirmation of abdominal hemorrhage by:

   * Direct visualization or
   * Positive Focused Assessment with Sonography in Trauma (FAST) or
   * Diagnostic Peritoneal Aspiration (DPA)
4. No other known, uncontrolled active sources of hemorrhage
5. Subject is intubated and sedated per local guidelines
6. Decision to administer foam is made within 30 minutes of admission to the emergency department.
7. Decision made to proceed to emergent laparotomy made within 30 minutes of admission to the emergency department.
8. Definitive surgical care is expected to occur within three hours of foam deployment
9. Subject must also be receiving concurrent transfusion of fluids or blood products.

   Exclusion Criteria:
10. Known or suspected major diaphragm injury
11. Known or suspected untreated pneumothorax
12. Known or suspected untreated hemothorax
13. Known or suspected blunt or penetrating cardiac or thoracic aortic trauma
14. Traumatic brain injury resulting in decapitation, visible brain matter or considered non- survivable based on initial physical exam
15. Received greater than five consecutive minutes of cardiopulmonary resuscitation in the pre-emergency department setting
16. Patients with Pulseless Electrical Activity
17. Known allergy to isocyanate
18. Known or suspected pregnancy
19. History of prior abdominal surgery or evidence of abdominal surgery (scars)
20. Disrupted abdominal wall that, in the opinion of the investigator would preclude ResQFoam from being adequately contained within the abdominal cavity
21. Subject in whom the abdominal aortic junctional tourniquet (AAJT) or Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) techniques have been used
22. Known Prisoners
23. Subjects with burns \> 20% of total body surface area
24. Subject/legally authorized representative/subject family member purposefully opted out of participation in the study
25. Known Do Not Resuscitate order (DNR) or Physician Orders for Life Sustaining Treatment (POLST)
26. Known enrollment in another randomized, interventional study

Where it's running

• University of Alabama at Birmingham
  Birmingham, Alabama, United States Recruiting
• University of Cincinnati
  Cincinnati, Ohio, United States Recruiting

Study contacts

• Principal investigator: Timothy Pritts, MD — University of Cincinnati
• Study coordinator: Carol Pekar, RAC
• Email: cpekar@arsenalmedical.com
• Phone: 508-523-5456

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Suction versus water-seal chest tube management for traumatic hemothorax/hemopneumothorax

  This trial will try whether starting chest tubes on suction or keeping them on a water seal helps adults with traumatic hemothorax or hemopneumothorax get their tubes out sooner and recover faster.

  Recruiting Vanderbilt University Medical Center · Nashville, Tennessee · NCT07551791

• Gastric emptying and feeding tolerance in ICU patients by vasopressor dose

  This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.

  Recruiting Başakşehir Çam & Sakura City Hospital · Istanbul · NCT07802379

• Argos system to track cardiac output changes in critically ill patients

  This study tests whether the Argos monitor can reliably track how cardiac output changes after fluid administration or norepinephrine adjustments in critically ill adults already monitored with transpulmonary thermodilution.

  Recruiting Bicetre Hospital · Le Kremlin-Bicêtre · NCT07724262

• Pulse palpation vs arterial blood pressure in circulatory shock

  This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.

  Recruiting Region Stockholm · Stockholm, Stockholm County · NCT07609095

• Femoral vein-to-artery diameter ratio to predict fluid responsiveness

  This project will test whether a bedside ultrasound measurement of the femoral vein-to-artery diameter ratio can tell if mechanically ventilated ICU patients with acute circulatory failure or shock will increase their cardiac output after a 500 mL fluid bolus.

  Recruiting Istanbul University - Cerrahpasa · Istanbul, Istanbul · NCT07546656

• Right ventricular–arterial coupling during fluid loading in ICU patients

  This study tests how the right ventricle handles fluid changes in critically ill adults to see how it affects blood flow and congestion.

  Recruiting CHU de Reims · Reims · NCT07537621

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.